Trial Profile
A comparative study of three types of treatment for Attention-Deficit/Hyperactivity Disorder in children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 22 Jan 2018 New trial record